Same thing has happened in prior reporting periods. Dump on the news syndrome.
If history does repeat, next year OSIR will be $30 at this time....
short term holders have bailed in the meantime. Buh bye.
Sentiment: Strong Buy
As I have said before, it's somewhat of a positive when we don't have rumors and big run ups to earnings. No pump and dump leads to gradual increases in price rather that wild swings. We're up %50 year to date.
You must be missing the big picture. OSIR resembles an early Microsoft which produces several variations on a theme. I doubt they'd sell just based on the development of a certain spine therapy when there are countless other potential developments based on a rapidly expanding safe platform. We haven't even scratched the surface potential.
Well Ati, it took time...but just as you sensed a few years back with coated stents to increase blood flow, this is cutting edge. CHF has had few solutions to improve a chronic decline in health. This is huge....regenerative indeed.